Literature DB >> 21744112

Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease.

Flavio Nobili1, Dario Arnaldi, Claudio Campus, Michela Ferrara, Fabrizio De Carli, Andrea Brugnolo, Barbara Dessi, Nicola Girtler, Silvia Morbelli, Giovanni Abruzzese, Gianmario Sambuceti, Guido Rodriguez.   

Abstract

PURPOSE: Subtle cognitive impairment is recognized in the first stages of Parkinson's disease (PD), including executive, memory and visuospatial dysfunction, but its pathophysiological basis is still debated.
METHODS: Twenty-six consecutive, drug-naïve, de novo PD patients underwent an extended neuropsychological battery, dopamine transporter (DAT) and brain perfusion single photon emission computed tomography (SPECT). We previously reported that nigrocaudate impairment correlates with executive functions, and nigroputaminal impairment with visuospatial abilities. Here perfusion SPECT was first compared between the PD group and age-matched controls (CTR). Then, perfusion SPECT was correlated with both DAT SPECT and four neuropsychological factors by means of voxel-based analysis (SPM8) with a height threshold of p < 0.005 at peak level and p < 0.05 false discovery rate-corrected at cluster level. Both perfusion and DAT SPECT images were flipped in order to have the more affected hemisphere (MAH), defined clinically, on the same side.
RESULTS: Significant hypoperfusion was found in an occipital area of the MAH in PD patients as compared to CTR. Executive functions directly correlated with brain perfusion in bilateral posterior cingulate cortex and precuneus in the less affected hemisphere (LAH), while verbal memory directly correlated with perfusion in the precuneus, inferior parietal lobule and superior temporal gyrus in the LAH. Furthermore, positive correlation was highlighted between nigrocaudate and nigroputaminal impairment and brain perfusion in the precuneus, posterior cingulate and parahippocampal gyri of the LAH.
CONCLUSION: These data support the evidence showing an early involvement of the cholinergic system in the early cognitive dysfunction and point to a more relevant role of parietal lobes and posterior cingulate in executive functions in PD.

Entities:  

Mesh:

Year:  2011        PMID: 21744112     DOI: 10.1007/s00259-011-1874-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  54 in total

1.  European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands.

Authors:  K Tatsch; S Asenbaum; P Bartenstein; A Catafau; C Halldin; L S Pilowsky; A Pupi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10       Impact factor: 9.236

2.  Gait asymmetry in patients with Parkinson's disease and elderly fallers: when does the bilateral coordination of gait require attention?

Authors:  Galit Yogev; Meir Plotnik; Chava Peretz; Nir Giladi; Jeffrey M Hausdorff
Journal:  Exp Brain Res       Date:  2007-03       Impact factor: 1.972

3.  The mind's eye--precuneus activation in memory-related imagery.

Authors:  P C Fletcher; C D Frith; S C Baker; T Shallice; R S Frackowiak; R J Dolan
Journal:  Neuroimage       Date:  1995-09       Impact factor: 6.556

4.  Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.

Authors:  Flavio Nobili; Andrea Brugnolo; Piero Calvini; Francesco Copello; Caterina De Leo; Nicola Girtler; Silvia Morbelli; Arnoldo Piccardo; Paolo Vitali; Guido Rodriguez
Journal:  Clin Neurophysiol       Date:  2005-02       Impact factor: 3.708

5.  Exploring the unity and diversity of the neural substrates of executive functioning.

Authors:  Fabienne Collette; Martial Van der Linden; Steven Laureys; Guy Delfiore; Christian Degueldre; Andre Luxen; Eric Salmon
Journal:  Hum Brain Mapp       Date:  2005-08       Impact factor: 5.038

6.  Network modulation in the treatment of Parkinson's disease.

Authors:  Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael G Kaplitt; Andrew Feigin; David Eidelberg
Journal:  Brain       Date:  2006-07-14       Impact factor: 13.501

7.  The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization.

Authors:  B Desgranges; J C Baron; V de la Sayette; M C Petit-Taboué; K Benali; B Landeau; B Lechevalier; F Eustache
Journal:  Brain       Date:  1998-04       Impact factor: 13.501

8.  Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent.

Authors:  Heidi I L Jacobs; Pieter Jelle Visser; Martin P J Van Boxtel; Giovanni B Frisoni; Magda Tsolaki; Panagiota Papapostolou; Flavio Nobili; Lars-Olof Wahlund; Lennart Minthon; Lutz Frölich; Harald Hampel; Hilkka Soininen; Laura van de Pol; Philip Scheltens; Frans E S Tan; Jelle Jolles; Frans R J Verhey
Journal:  Neurobiol Aging       Date:  2010-08-23       Impact factor: 4.673

9.  Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study.

Authors:  Flavio Nobili; Claudio Campus; Dario Arnaldi; Fabrizio De Carli; Gaia Cabassi; Andrea Brugnolo; Barbara Dessi; Silvia Morbelli; Gianmario Sambuceti; Giovanni Abbruzzese; Guido Rodriguez
Journal:  Mov Disord       Date:  2010-01-15       Impact factor: 10.338

10.  White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.

Authors:  Turi O Dalaker; Jan P Larsen; Michael G Dwyer; Dag Aarsland; Mona K Beyer; Guido Alves; Kolbjorn Bronnick; Ole-Bjorn Tysnes; Robert Zivadinov
Journal:  Neuroimage       Date:  2009-06-16       Impact factor: 6.556

View more
  14 in total

1.  Brain (18)F-DOPA PET and cognition in de novo Parkinson's disease.

Authors:  Agnese Picco; Silvia Morbelli; Arnoldo Piccardo; Dario Arnaldi; Nicola Girtler; Andrea Brugnolo; Irene Bossert; Lucio Marinelli; Antonio Castaldi; Fabrizio De Carli; Claudio Campus; Giovanni Abbruzzese; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-28       Impact factor: 9.236

2.  Limbic hypoconnectivity in idiopathic REM sleep behaviour disorder with impulse control disorders.

Authors:  Ana Marques; Daniel Roquet; Elie Matar; Natasha Louise Taylor; Bruno Pereira; Claire O'Callaghan; Simon J G Lewis
Journal:  J Neurol       Date:  2021-03-11       Impact factor: 4.849

3.  Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database.

Authors:  Flavio Nobili; Mehrdad Naseri; Fabrizio De Carli; Susan Asenbaum; Jan Booij; Jacques Darcourt; Peter Ell; Ozlem Kapucu; Paul Kemp; Claus Svarer; Claus Varer; Silvia Morbelli; Marco Pagani; Osama Sabri; Klaus Tatsch; Livia Tossici-Bolt; Terez Sera; Tierry Vander Borght; Koen Van Laere; Andrea Varrone
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-12       Impact factor: 9.236

4.  Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients.

Authors:  Pietro Mattioli; Matteo Pardini; Francesco Famà; Nicola Girtler; Andrea Brugnolo; Beatrice Orso; Riccardo Meli; Laura Filippi; Stefano Grisanti; Federico Massa; Matteo Bauckneht; Alberto Miceli; Michele Terzaghi; Silvia Morbelli; Flavio Nobili; Dario Arnaldi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-28       Impact factor: 9.236

5.  Structural and physiological neurovascular changes in idiopathic Parkinson's disease and its clinical phenotypes.

Authors:  Sarah Al-Bachari; Rishma Vidyasagar; Hedley Ca Emsley; Laura M Parkes
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-23       Impact factor: 6.200

6.  Striatal Dopaminergic Depletion Pattern Reflects Pathological Brain Perfusion Changes in Lewy Body Diseases.

Authors:  Yu Iwabuchi; Tohru Shiga; Masashi Kameyama; Raita Miyazawa; Morinobu Seki; Daisuke Ito; Hiroyuki Uchida; Hajime Tabuchi; Masahiro Jinzaki
Journal:  Mol Imaging Biol       Date:  2022-06-14       Impact factor: 3.488

7.  Altered nigrostriatal and nigrocortical functional connectivity in rapid eye movement sleep behavior disorder.

Authors:  Timothy M Ellmore; Richard J Castriotta; Katie L Hendley; Brian M Aalbers; Erin Furr-Stimming; Ashley J Hood; Jessika Suescun; Michelle R Beurlot; Roy T Hendley; Mya C Schiess
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

8.  Correlations between dopamine transporter density measured by 123I-FP-CIT SPECT and regional gray matter volume in Parkinson's disease.

Authors:  Tomoko Maekawa; Noriko Sato; Miho Ota; Atsuhiko Sugiyama; Daichi Sone; Mikako Enokizono; Yukio Kimura; Youhei Mukai; Miho Murata; Harumasa Takano; Etsuko Imabayashi; Hiroshi Matsuda; Akira Kunimatsu; Osamu Abe
Journal:  Jpn J Radiol       Date:  2017-10-23       Impact factor: 2.374

Review 9.  Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a review.

Authors:  Michele Poletti; Ubaldo Bonuccelli
Journal:  Ther Adv Psychopharmacol       Date:  2013-04

Review 10.  Neural and behavioral substrates of subtypes of Parkinson's disease.

Authors:  Ahmed A Moustafa; Michele Poletti
Journal:  Front Syst Neurosci       Date:  2013-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.